Scroll for more
news Jan 6, 2017

BenevolentAI gets The Economist thinking on biology and AI

We met with The Economist to discuss how artificial intelligence (AI) and machine learning is helping to crack and transform the scientific method.

In a far reaching article, The Economist covers our work on amyotrophic lateral sclerosis (ALS) with Dr Richard Mead, a neuroscientist at the University of Sheffield. Dr Mead describes how we have given him two ideas for drugs for ALS. Both molecules remain confidential while their utility is being assessed. One is bang in the middle of what he and his team are doing already. To him, this confirms that the AI in question is generating good ideas.

Read full article here